Eaton Vance Management Ani Pharmaceuticals Inc Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$26.91 - $47.15 $13,535 - $23,716	-503 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $9,792 - $16,884	297 Added 144.17%	503 $0
Q3 2021 Nov 15, 2021	SELL	$26.48 - $35.99 $1,562 - $2,123	-59 Reduced 22.26%	206 $0
Q2 2021 Aug 16, 2021	BUY	$31.86 - $38.6 $6,913 - $8,376	217 Added 452.08%	265 $9,000
Q1 2021 May 17, 2021	BUY	$28.4 - $36.14 $1,363 - $1,734	48 New	48 $2,000

211

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.